I do not think the 10.50 per share refers to CDCAQ, but instead to CDCS. Still, if true, since there are 35 million shares outstanding, that's $250M/35M or $7.14 in cash per share of CDCAQ. Certainly better than the present $2.5 per share of CDCAQ on the going market. It sounds like the better bet is to buy CDCS, if still possible, since it has been valued at $10.50 per share by this proposed deal. Is CDCS still trading?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.